Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Sep 22:6:8019.
doi: 10.1038/ncomms9019.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Heather J Cordell  1 , Younghun Han  2 , George F Mells  3 , Yafang Li  2 , Gideon M Hirschfield  4 , Casey S Greene  5 , Gang Xie  6 , Brian D Juran  7 , Dakai Zhu  2 , David C Qian  2 , James A B Floyd  8   9 , Katherine I Morley  8   10 , Daniele Prati  11 , Ana Lleo  12 , Daniele Cusi  13   14 ; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; M Eric Gershwin  15 , Carl A Anderson  8 , Konstantinos N Lazaridis  7 , Pietro Invernizzi  12   15 , Michael F Seldin  15 , Richard N Sandford  3 , Christopher I Amos  2 , Katherine A Siminovitch  6   16   17   18
Collaborators, Affiliations
Meta-Analysis

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Heather J Cordell et al. Nat Commun. .

Abstract

Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined<5 × 10(-8)) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.

PubMed Disclaimer

References

    1. Hirschfield G. M. & Gershwin M. E. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu. Rev. Pathol. 8, 303–330 (2013). - PubMed
    1. Hirschfield G. M. et al.. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360, 2544–2555 (2009). - PMC - PubMed
    1. Hirschfield G. M. et al.. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat. Genet. 42, 655–657 (2010). - PMC - PubMed
    1. Liu X. et al.. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42, 658–660 (2010). - PMC - PubMed
    1. Mells G. F. et al.. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 43, 329–332 (2011). - PMC - PubMed

Publication types

MeSH terms